| Literature DB >> 23762748 |
Shalini Duggal1, Rajni Gaind, Neha Tandon, Manorama Deb, Tulsi Das Chugh.
Abstract
The present study was designed to compare a fully automated identification/antibiotic susceptibility testing (AST) system BD Phoenix (BD) for its efficacy in rapid and accurate identification and AST with conventional manual methods and to determine if the errors reported in AST, such as the (very major errors) VME (false susceptibility), (major errors) ME (false resistance), and (minor errors) MiE (intermediate category interpretation) were within the range certified by FDA. Identification and antimicrobial susceptibility test results of eighty-five clinical isolates including both gram-positive and negative were compared on Phoenix considering the results obtained from conventional manual methods of identification and disc diffusion testing of antibiotics as standards for comparison. Phoenix performed favorably well. There was 100% concordance in identification for gram-negative isolates and 94.83% for gram-positive isolates. In seven cases, Phoenix proved better than conventional identification. For antibiotic results, categorical agreement was 98.02% for gram-positive and 95.7% for gram-negative isolates. VME was 0.33%, ME 0.66%, MiE 0.99% for gram-positive isolates and 1.23% VME, 1.23% ME, and 1.85% MiE for gram-negative isolates. Therefore, this automated system can be used as a tool to facilitate early identification and susceptibility pattern of aerobic bacteria in routine microbiology laboratories.Entities:
Year: 2012 PMID: 23762748 PMCID: PMC3664201 DOI: 10.5402/2012/107203
Source DB: PubMed Journal: ISRN Microbiol
Discordant results obtained for isolates by Phoenix as compared to Kirby-Bauer disk diffusion test.
| Antimicrobial ( | Organism | Phoenix AST | Disc diffusion | Interpretation |
|---|---|---|---|---|
| Erythromycin (1) |
| Susceptible | Resistant | Very major error |
| Vancomycin (1) |
| Resistant | Susceptible | Major error |
| Linezolid (2) | Intermediate | Susceptible | Minor errors | |
| Erythromycin (1) | Intermediate | Susceptible | Minor error | |
| Nitrofurantoin (1) | Resistant | Susceptible | Major error | |
| Piperacillin/tazobactam (3) |
| Sensitive | Resistant | Very major error |
| Cefepime (2) |
| Sensitive | Resistant | Very major error |
| Resistant | Intermediate | Minor error | ||
| Nitrofurantoin (1) |
| Intermediate | Susceptible | Minor error |
| Amikacin (3) |
| Resistant | Susceptible | Major error |
| Susceptible | Intermediate | Minor error | ||
|
| Resistant | Susceptible | Major error | |
| Ciprofloxacin (2) |
| Resistant | Intermediate | Minor error |
|
| Resistant | Susceptible | Major error | |
| Ceftriaxone (1) |
| Resistant | Intermediate | Minor error |
| Imipenem (1) |
| Resistant | Intermediate | Minor error |
| Ceftazidime (1) |
| Resistant | Susceptible | Major error |
*(n): Total number of discordant results.
Showing reproducibility of isolates on repeat testing in Phoenix.
| Isolate | Difference in identification | Difference in AST | Type of error |
|---|---|---|---|
|
| None | None | — |
|
| None | None | — |
|
|
| None | Identification |
|
| None | Chloramphenicol | Major error |
|
| None | None | — |
|
| None | Vancomycin | Major error |
|
| None | Nitrofurantoin (2) | Minor error |
| Moxifloxacin | Major error | ||
|
| None | Gatifloxacin | Minor error |
|
| None | None | — |
|
| None | AST not in Phoenix database | — |
|
| None | AST not in Phoenix database | — |
|
| None | AST not in Phoenix database | — |
|
| None | Piperacillin/Tazobactam | Minor error |
|
| None | None | — |
|
|
| AST not in Phoenix database | Identification |
|
| None | AST not in Phoenix database | — |
|
| None | None | — |
None: no difference found.